Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- BOTOX® Treatment in Pediatric Lower Limb Spasticity: Complete Statistical AnalysisIndependent statistical analysis of BOTOX® Treatment in Pediatric Lower Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01603628).
- BotticelliIndependent statistical analysis of Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each Monotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Botulin-A Toxin Instillations and Overactive Bladder: Complete Statistical AnalysisIndependent statistical analysis of Botulin-A Toxin Instillations and Overactive Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00583219).
- Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness: Complete Statistical AnalysisIndependent statistical analysis of Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb Joint: Complete Statistical AnalysisIndependent statistical analysis of Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb Joint: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BOULEVARDIndependent statistical analysis of A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia: Complete Statistical AnalysisIndependent statistical analysis of Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BPDIndependent statistical analysis of Bipolar Disorder in Late Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00787930).
- BPOITIndependent statistical analysis of Boiled Peanut Oral Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04090203).
- BPSIndependent statistical analysis of Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03243084).
- BRADYCAREIndependent statistical analysis of BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01062126).
- BradyXplore Phase II: Bradykinesia Feature Extraction System: Complete Statistical AnalysisIndependent statistical analysis of BradyXplore Phase II: Bradykinesia Feature Extraction System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02358876).
- BRAFIndependent statistical analysis of Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram: Complete Statistical AnalysisIndependent statistical analysis of Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Brain Stimulation and Cognitive Training: Complete Statistical AnalysisIndependent statistical analysis of Brain Stimulation and Cognitive Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03338673).
- Brain Stimulation and Enhancing Cognition in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Brain Stimulation and Enhancing Cognition in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03653351).
- Brain Stimulation and Robotics in Chronic Stroke Motor Recovery: Complete Statistical AnalysisIndependent statistical analysis of Brain Stimulation and Robotics in Chronic Stroke Motor Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03562663).
- Brain Training to Enhance Frontal Lobe Reasoning: Complete Statistical AnalysisIndependent statistical analysis of Brain Training to Enhance Frontal Lobe Reasoning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01552473).
- BrainRadioIndependent statistical analysis of Neural Signatures of Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01990313).
- BRAVE-EPAIndependent statistical analysis of Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02719327).
- BRAVOIndependent statistical analysis of A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO): primary endpoint results, effect estimate with…
- BRAVOIndependent statistical analysis of BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®): primary endpoint results, effect estimate…
- BRE-43Independent statistical analysis of Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation: Complete Statistical AnalysisIndependent statistical analysis of Breaking Down Care Process and Patient-level Barriers to Arteriovenous Access Creation Prior to Hemodialysis Initiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01817374).
- BreastCAREIndependent statistical analysis of Breast Cancer Risk Reduction: A Patient Doctor Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01830933).
- BREATHEIndependent statistical analysis of Bronchiolitis Recovery and the Use of High Efficiency Particulate Air (HEPA) Filters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BREATHEIndependent statistical analysis of Relaxation Treatment for Anxiety in Adults Aged 60 or Older: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02429778).
- BreEStim and tDCS for Neuropathic Pain Management – Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of BreEStim and tDCS for Neuropathic Pain Management - Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03302780).
- Breier-StanleyIndependent statistical analysis of The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level: Complete Statistical AnalysisIndependent statistical analysis of Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients: Complete Statistical AnalysisIndependent statistical analysis of Brentuximab Vedotin and Chemotherapy in CD30+ PMBL, Diffuse Large B-Cell, and Grey Zone Lymphoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- BretuximabIndependent statistical analysis of Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy: Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD): Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer’s Type: Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer’s Type: Complete Statistical AnalysisIndependent statistical analysis of Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- BridgeIndependent statistical analysis of Maintenance of Platelet Inhibition With Cangrelor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00767507).
- BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control: Complete Statistical AnalysisIndependent statistical analysis of BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04365465).
- BRIDGESIndependent statistical analysis of Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00862745).
- Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers: Complete Statistical AnalysisIndependent statistical analysis of Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03974061).
- Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans: Complete Statistical AnalysisIndependent statistical analysis of Brief Cognitive Behavioral Therapy for Chronic Pain to Improve Functioning Among Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Brief Cognitive Behavioral Therapy for Military Populations: Complete Statistical AnalysisIndependent statistical analysis of Brief Cognitive Behavioral Therapy for Military Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02038075).
- Brief Educational Video for Patients Prescribed LTBI Treatment: Complete Statistical AnalysisIndependent statistical analysis of Brief Educational Video for Patients Prescribed LTBI Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05412212).
- Brief Electronic Intervention for Heavy Drinking and Sex Risk Among MSM Seeking HIV Testing: Complete Statistical AnalysisIndependent statistical analysis of Brief Electronic Intervention for Heavy Drinking and Sex Risk Among MSM Seeking HIV Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Brief Group Psychoeducation for Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Brief Group Psychoeducation for Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02911519).
- Brief Intervention for Justice-Involved Substance Users: Complete Statistical AnalysisIndependent statistical analysis of Brief Intervention for Justice-Involved Substance Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03308877).
- Brigatinib Before Brain Irradiation Trial (B3i Trial): Complete Statistical AnalysisIndependent statistical analysis of Brigatinib Before Brain Irradiation Trial (B3i Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04634110).